Start with the latest view of this part of the market. Then see which stock ideas are ready, which promising ideas still need work, and which event could change the answer.
0 ready·1 under review·2 lower-priority
The broad universe still offers the best raw material in asset-backed shipping, contracted infrastructure, defense production capacity and cash-generative materials businesses. The problem is catalyst quality: many candidates have good current fundamentals, but the next observable events are ordinary earnings, discretionary repurchases, commodity-rate moves or management-guided improvements rather than a hard valuation unlock. A sharper price reset, binding contract award, scheduled investor-day reset or asset-sale/deleveraging event would improve the opportunity set.
No material change from the 2026-08-28 sweep: current issuer evidence rechecked shipping, mining/materials, defense, infrastructure and insurance without finding a new 8/10 setup.
Did any issuer schedule a hard Q4 2026 investor day, contract award, asset sale or capital-return event after this sweep?
Facts checked through Aug 28, 2026 · saved Aug 28, 2026
The broad universe still looks active but not cleanly mispriced at the required bar. The best hunting ground remains asset-backed or contracted-revenue businesses with issuer-dated catalysts, but many current setups rely on macro variables, routine earnings confirmation, or already-visible capital returns rather than a clear market error. A better opportunity would require a sharper valuation reset, a dated investor-day or filing catalyst, and downside supported by assets or contracted cash flow.
These ideas passed every required check. The same answer appears on Today, Ideas, and the stock’s own page.
No stock in this area has passed every check yet. Promising ideas remain visible below with the exact work still needed.
Researchers see a strong case, but one or more required checks are unfinished. We show every missing item so a strong story is never mistaken for a ready idea.
Next: open the Idea to see the fact or date we will check.
Q3 2026 earnings and supplemental variable dividend declaration reflecting elevated tanker rates
Record Q2 2026: net income $295M, adjusted EBITDA $345M, EPS $5.91 beat. Q2 blended spot TCE reached $79,000/day (vs $27,500/day a year ago). Company declared its largest-ever quarterly dividend of $5.05/share payable September 2026, reflecting the 85%-payout policy in full force. Q3 2026 forward bookings: ~48% of revenue days booked at ~$61,000/day blended spot TCE—well above the $35,000/day invalidation threshold. TD3C rates in Week 32 2026 (early August) remained elevated. Thesis outperforming.
Record Q2 2026 (reported early August 2026): net income $295M, FCF $261M, EPS $5.91 beat $5.52 consensus; revenue $467.29M vs $401.77M expected, +139% YoY. Largest quarterly dividend in company history declared at $5.05/share, payable Sept 24, 2026 — third consecutive quarter at ≥85% payout of adjusted net income. VLCC rates remain far above the $35K/day invalidation trigger: TD3c peaked above $420K/day in March 2026 and stayed elevated through Q2. All thesis pillars (elevated rates, record earnings, large dividend) are delivering ahead of expectations; bumping conviction to 7.
Open the Idea for the saved explanation.
Open the Idea for the saved explanation.
Open the Idea for the saved explanation.
Open the Idea for the saved explanation.
Open the Idea for the saved explanation.
Open the Idea for the saved explanation.
Open the Idea for the saved explanation.
Open the Idea for the saved explanation.
Open the Idea for the saved explanation.
Open the Idea for the saved explanation.
No idea has ended in this area yet.
Sector-agnostic opportunity hunting: industrials, defense, shipping, mining, financials, consumer, infrastructure, materials — anything mispriced with a concrete catalyst that does not belong cleanly in a specialist universe
A research-strength rating of 8/10 lets an idea enter the public review list; it does not make the idea ready. Readiness also requires a recent review, a saved starting price, an active target, current risk research, a clear way the idea could be proven wrong, dated sources for important claims, all six confidence checks, a usable market price and currency, and a clear next test.